The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Abstract

PURPOSE The aim of this study was to determine the prognostic value of the chemokine CCL5, considered as a promalignancy factor in breast cancer, in predicting breast cancer progression and to evaluate its ability to strengthen the prognostic significance of other biomarkers. EXPERIMENTAL DESIGN The expression of CCL5, alone and in conjunction with… (More)

Topics

  • Presentations referencing similar topics